Sana Biotechnology, Inc. Common Stock
$3.10
$0.00 (+0.00%)
$3.02Day Range$3.11
Key Statistics
Market Cap
$928.02M
Shares Outstanding
299.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 4, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$3.09
Day High
$3.11
Day Low
$3.02
Volume
7.38M
VWAP
$3.09
Prev Close
$3.10
Transactions
--
Acc. Volume
--
About Sana Biotechnology, Inc. Common Stock
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836142 employees188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA(206) 701-7914IPO Feb 4, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001770121
- Composite FIGI
- BBG00N5BMH61
- Share Class FIGI
- BBG00N5BMH70
- Ticker Root
- SANA
- SIC Code
- 2836
About Sana Biotechnology, Inc. Common Stock (SANA) Stock
Sana Biotechnology, Inc. Common Stock (SANA) closed the 2026-09-18 session at $3.10, up 0.00% versus the previous close (+0.00). The stock opened at $3.09 and traded between $3.02 and $3.11 during that session. Session trading volume was 7.4M shares. The volume-weighted average price (VWAP) is $3.09.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Sana Biotechnology, Inc. Common Stock has a market capitalization of $928.0 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. SANA is listed on the XNAS exchange. The company employs approximately 142 people. Sana Biotechnology, Inc. Common Stock is headquartered in SEATTLE, WA. The recorded listing date is 2021-02-04.
On this page you can find market SANA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.